Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
After 10 Years, US FDA ‘Additional Conditions’ Proposed Rule Offers ‘Novel Switch’ Pathway
Jun 29 2022
•
By
Hannah Daniel
The new proposed rule was not developed in a straight line over the last several years. • Source: Shutterstock
More from Approval Standards
More from Pathways & Standards